Adjuvant Chemotherapy: Current Practices, Efficacy and Future Directions


Yasushi Tsuji, M.D., Ph.D. (Editor)
KKR Sapporo Medical Center, Tonan Hospital, Sapporo, Hokkaido, Japan

Series: Cancer Etiology, Diagnosis and Treatments
BISAC: MED012000

In the age of constant knowledge via computer accessibility, the effort to write a book on adjuvant chemotherapy may seem almost futile. However, the information seen online is usually fragmented, without context, and often somewhat unreliable. This book aims to provide a handy and reliable reference to better understand both the current situation and the future directions in the field of adjuvant chemotherapy. Its ten chapters covering major cancers were written by prominent researchers with decades of experience in clinical settings as well as in related fields of research.

Owing mostly to the development of novel cancer drugs, cytotoxic agents, targeting agents and immune check point inhibitors, the prognosis of all cancers has markedly improved. On the other hand, determining the best way to use these drugs is becoming more and more complicated, and most patients after recurrence are still unlikely to be cured. Carefully planned and meticulously executed surgery, appropriate adjuvant chemotherapy and radiotherapy still play major roles in treatment, and they can significantly increase cure rates, especially in the advanced stages. This book contains a wealth of the latest international data and detailed information assist professionals in making the best possible decisions regarding specific and patient-oriented treatments.

From the general introduction to the principles of adjuvant chemotherapy in chapter one to all the details in the chapters covering specific cancers, we hope this book will inspire veterans in the field with new ideas and help to guide and educate young doctors and researchers, all towards the ultimate goal of providing better care for our patients.

Table of Contents

Table of Contents


Chapter 1. Basic Principles of Adjuvant Chemotherapy
(François-Michel Delgado, Maria Angeles Gil-Delgado, and David Khaya, Service d’Oncologie Médicale, Groupe Hospitalier Pitié Salpêtrière, Paris, France, and others)

Chapter 2. Early-Stage Breast Cancer
(Aydah Al-Awadhi and Gabriel N. Hortobagyi, Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, US, and others)

Chapter 3. Adjuvant Chemotherapy in Lung Cancer
Hidehito Horinouchi, MD, PhD, Department of Thoracic Oncology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan)

Chapter 4. Upper Gastrointestinal Cancer
(Yasushi Sato and Tetsuji Takayama, Department of Community Medicine for Gastroenterology and Oncology, Graduate School of Medical Science, Tokushima University, Tokushima, Japan)

Chapter 5. Colon Cancer
(Yasushi Tsuji, MD, PhD, Department of Medical Oncology, Tonan Hospital, Chuo-ku, Sapporo, Japan)

Chapter 6. Rectal Cancer
(Yojiro Hashiguchi, MD, PhD, Department of Surgery, Teikyo University School of Medicine, Kaga, Itabashi-Ku, Tokyo, Japan)

Chapter 7. Pancreatic Cancer and Biliary Cancer
(Takahiro Tsushima, MD, Division of Gastrointestinal Oncology, Shizuoka Cancer Centre, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka Prefecture, Japan)

Chapter 8. Gastrointestinal Stromal Tumor
(Yoshito Komatsu, MD, PhD, Hokkaido University Hospital Cancer Center, Kita-ku, Sapporo, Japan)

Chapter 9. Urologic Cancers
(Hiroshi Kitamura, MD, PhD, Department of Urology, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Sugitani, Toyama, Japan)

Chapter 10. Ovarian Cancer Revision of the Dogma Can Be Maintained
(Aimery de Gramont, MD, PhD and Benoist Chibaudel, MD, Institut hospitalier Franco-Britannique, Levallois Perret, France)


Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!